logo
Select company
Select metric
0%Debt to Assets Ratio
VS
Market
93
Sector
90
Industry
94
History
61
$ 2.43Close
$ 2 - $ 29.07 52-Week Range
Ticker Information

Ticker

BBLG

Company Name

BONE BIOLOGICS CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

BONE BIOLOGICS CORP - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBLG - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 7M$ 00%
3/31/2025$ 3.16M$ 00%
12/31/2024$ 3.86M$ 00%
9/30/2024$ 4.07M$ 00%
6/30/2024$ 3.19M$ 00%
3/31/2024$ 3.84M$ 00%
12/31/2023$ 3.74M$ 00%
9/30/2023$ 4.98M$ 00%
6/30/2023$ 7.62M$ 00%
3/31/2023$ 6.78M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for BONE BIOLOGICS CORP is calculated as follows: Debt [ $ 11.72M ] / Assets [ $ 0 ]
(=) Debt to Assets [ 0% ]

BBLG - Debt to Assets Ratio, Last 5 years

0%

Minimum

Dec 31, 2021

281459.89%

Maximum

Jun 30, 2021

17921.22%

Average

0%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.33% with a standard deviation of 24.49%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.37K
min0%
max116.6%
average26.33%
median21.09%
std24.49%